GPS Wealth Strategies Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31
Closed -$943 1360
2024
Q1
$943 Hold
31
﹤0.01% 1171
2023
Q4
$1.11K Hold
31
﹤0.01% 1153
2023
Q3
$1.36K Hold
31
﹤0.01% 1156
2023
Q2
$1.53K Hold
31
﹤0.01% 1132
2023
Q1
$1.28K Buy
+31
New +$1.29K ﹤0.01% 1144
2022
Q4
Sell
-62
Closed -$2K 173
2022
Q3
$2K Hold
62
﹤0.01% 1022
2022
Q2
$3K Hold
62
﹤0.01% 959
2022
Q1
$4K Buy
62
+31
+100% +$2.01K ﹤0.01% 868
2021
Q4
$2K Hold
31
﹤0.01% 969
2021
Q3
$2K Hold
31
﹤0.01% 934
2021
Q2
$2K Hold
31
﹤0.01% 950
2021
Q1
$2K Buy
+31
New +$1.91K ﹤0.01% 849

Other funds holding ATRC

GPS Wealth Strategies Group's ATRC Position: Q2 2024 in Review

GPS Wealth Strategies Group sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 31 shares — an estimated $943 sold.

GPS Wealth Strategies Group first reported a position in ATRC in Q1 2021 and held it in 12 quarters. The position peaked at $4K in Q1 2022. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • GPS Wealth Strategies Group reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 31 AtriCure shares in Q2 2024, an estimated $943.
  • GPS Wealth Strategies Group first reported a position in AtriCure in Q1 2021 and held it in 12 quarters.
  • GPS Wealth Strategies Group's AtriCure position peaked at $4K in Q1 2022.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q2 2024, filed 16 Jul 2024.